^
+ Follow ANNUAL WORLD HEALTH Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 83359
                    [Title] => Partnership on COPD treatment bared
                    [Summary] => Boehringer Ingelheim and Pfizer Inc. have entered into a long-term worldwide agreement to jointly market Spiriva (tiotropium), a novel once-a-day inhaled treatment for Chronic Obstructive Pulmonary Disease (COPD), which includes chronic bronchitis and emphysema. 


Boehringer Ingelheim has filed for marketing approval with regulatory authorities in Europe, where Spiriva could be available as early as mid-2002.

A new drug application for Spiriva is anticipated to be filed with the US Food and Drug Administration later this year.
[DatePublished] => 2001-04-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
ANNUAL WORLD HEALTH
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 83359
                    [Title] => Partnership on COPD treatment bared
                    [Summary] => Boehringer Ingelheim and Pfizer Inc. have entered into a long-term worldwide agreement to jointly market Spiriva (tiotropium), a novel once-a-day inhaled treatment for Chronic Obstructive Pulmonary Disease (COPD), which includes chronic bronchitis and emphysema. 


Boehringer Ingelheim has filed for marketing approval with regulatory authorities in Europe, where Spiriva could be available as early as mid-2002.

A new drug application for Spiriva is anticipated to be filed with the US Food and Drug Administration later this year.
[DatePublished] => 2001-04-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with